14C-urea breath test in patients undergoing anti-tuberculosis therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

436

HTML

2590

Tables (1-2)

197

Sum=3223

Mar 21, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 21, 2005; 11(11): 1712-1714
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1712

Table 2 ¹⁴C-urea breath test results among 35 patients during the course of anti-tuberculosis therapy.

	Baseline	End of 2nd mo of therapy	End of treatment course	One month after completion on therapy
Positive (%)	35 (100)	0 (0)	4(11.4)	22 (62.9)
Negative (%)	0 (0)	35 (100)	30 (85.7)	13(37.1)

Citation: Mirbagheri SA, Sohrabpour AA, Hasibi M, Moghimi B, Mohamadnejad M. ¹⁴C-urea breath test in patients undergoing anti-tuberculosis therapy. World J Gastroenterol 2005; 11(11): 1712-1714
URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1712.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i11.1712